سیناکالست (Persian Wikipedia)
Analysis of information sources in references of the Wikipedia article "سیناکالست" in Persian language version.
refsWebsite
Global rank
Persian rank
1st place
1st place
low place
low place
3,823rd place
1,188th place
712th place
621st place
4,294th place
1,244th place
businessweek.com
- Edney, Anna (فوریه 26, 2013). "Amgen Pediatric Trials of Sensipar Halted by FDA After Death". بلومبرگ بیزنسویک. Archived from the original on March 2, 2013. Retrieved February 26, 2013.
drugbank.ca
drugs.com
- "Cinacalcet (Sensipar) Use During Pregnancy". Drugs.com. 19 July 2019. Retrieved 24 December 2019.
- "U.S. Pharmaceutical Statistics". Drugs.com. February 2014. Retrieved 13 July 2020.
- "Sales Statistics for Sensipar Prescriptions". Drugs.com. 2 September 2020. Retrieved 8 September 2020.
fda.gov
accessdata.fda.gov
- "Drug Approval Package: Sensipar (Cinacalcet HCI) NDA #021688". U.S. سازمان غذا و دارو (آمریکا) (FDA). 7 December 2019. Archived from the original on 7 December 2019. Retrieved 7 December 2019.
This article incorporates text from this source, which is in the public domain. - "Sensipar". U.S. سازمان غذا و دارو (آمریکا) (FDA). Archived from the original on 7 December 2019. Retrieved 7 December 2019. This article incorporates text from this source, which is in the public domain.
fda.gov
- "FDA Drug Safety Communication: Pediatric clinical studies of Sensipar (cinacalcet hydrochloride) suspended after report of death". U.S. سازمان غذا و دارو (آمریکا) (FDA). 15 January 2016. Archived from the original on 24 December 2019. Retrieved 23 December 2019. This article incorporates text from this source, which is in the public domain.
medicines.org.uk
- "Mimpara 30 mg Film-coated Tablets - Summary of Product Characteristics (SmPC)". electronic medicines compendium (emc). 8 July 2019. Archived from the original on 7 December 2019. Retrieved 7 December 2019.
nih.gov
dailymed.nlm.nih.gov
- "Sensipar- cinacalcet hydrochloride tablet, coated". DailyMed. 5 December 2019. Retrieved 24 December 2019.
nps.org.au
- "Sensipar Tablets". NPS MedicineWise. 1 May 2018. Archived from the original on 7 December 2019. Retrieved 7 December 2019.
web.archive.org
- "Sensipar Tablets". NPS MedicineWise. 1 May 2018. Archived from the original on 7 December 2019. Retrieved 7 December 2019.
- "Mimpara 30 mg Film-coated Tablets - Summary of Product Characteristics (SmPC)". electronic medicines compendium (emc). 8 July 2019. Archived from the original on 7 December 2019. Retrieved 7 December 2019.
- "Drug Approval Package: Sensipar (Cinacalcet HCI) NDA #021688". U.S. سازمان غذا و دارو (آمریکا) (FDA). 7 December 2019. Archived from the original on 7 December 2019. Retrieved 7 December 2019. This article incorporates text from this source, which is in the public domain.
- "Sensipar". U.S. سازمان غذا و دارو (آمریکا) (FDA). Archived from the original on 7 December 2019. Retrieved 7 December 2019. This article incorporates text from this source, which is in the public domain.
- "FDA Drug Safety Communication: Pediatric clinical studies of Sensipar (cinacalcet hydrochloride) suspended after report of death". U.S. سازمان غذا و دارو (آمریکا) (FDA). 15 January 2016. Archived from the original on 24 December 2019. Retrieved 23 December 2019. This article incorporates text from this source, which is in the public domain.
- Edney, Anna (فوریه 26, 2013). "Amgen Pediatric Trials of Sensipar Halted by FDA After Death". بلومبرگ بیزنسویک. Archived from the original on March 2, 2013. Retrieved February 26, 2013.